Innate defense against influenza A virus: activity of human neutrophil defensins and interactions of defensins with surfactant protein D.

PubWeight™: 1.33‹?› | Rank: Top 10%

🔗 View Article (PMID 16709857)

Published in J Immunol on June 01, 2006

Authors

Kevan L Hartshorn1, Mitchell R White, Tesfaldet Tecle, Uffe Holmskov, Erika C Crouch

Author Affiliations

1: Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA. khartsho@bu.edu

Articles citing this

N-linked glycosylation attenuates H3N2 influenza viruses. J Virol (2007) 1.92

Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection. J Immunol (2009) 1.86

A serpin shapes the extracellular environment to prevent influenza A virus maturation. Cell (2015) 1.57

The early whole-blood transcriptional signature of dengue virus and features associated with progression to dengue shock syndrome in Vietnamese children and young adults. J Virol (2010) 1.47

The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of mice. Respir Res (2008) 1.46

Antiviral mechanisms of human defensins. J Mol Biol (2013) 1.22

Host defense peptides in the oral cavity and the lung: similarities and differences. J Dent Res (2008) 1.19

Multiple components contribute to ability of saliva to inhibit influenza viruses. Oral Microbiol Immunol (2009) 1.13

Reduced influenza viral neutralizing activity of natural human trimers of surfactant protein D. Respir Res (2007) 1.10

Phosphatidylglycerol suppresses influenza A virus infection. Am J Respir Cell Mol Biol (2011) 1.01

Innate immunity to influenza virus: implications for future therapy. Expert Rev Clin Immunol (2008) 0.99

The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins. J Gen Virol (2012) 0.98

Mammalian innate resistance to highly pathogenic avian influenza H5N1 virus infection is mediated through reduced proinflammation and infectious virus release. J Virol (2012) 0.92

Loss of a single N-linked glycan from the hemagglutinin of influenza virus is associated with resistance to collectins and increased virulence in mice. Respir Res (2009) 0.92

Cationic host defence peptides: potential as antiviral therapeutics. BioDrugs (2013) 0.92

Differential pathological and immune responses in newly weaned ferrets are associated with a mild clinical outcome of pandemic 2009 H1N1 infection. J Virol (2012) 0.91

A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection. PLoS One (2011) 0.91

Galectin-1 binds to influenza virus and ameliorates influenza virus pathogenesis. J Virol (2011) 0.90

Diverse functions of pulmonary collectins in host defense of the lung. J Biomed Biotechnol (2012) 0.84

Alzheimer's associated β-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes. PLoS One (2014) 0.82

Surface-bound myeloperoxidase is a ligand for recognition of late apoptotic neutrophils by human lung surfactant proteins A and D. Protein Cell (2010) 0.82

Hapivirins and diprovirins: novel θ-defensin analogs with potent activity against influenza A virus. J Immunol (2012) 0.82

The threat of avian influenza a (H5N1): part II: Clues to pathogenicity and pathology. Med Microbiol Immunol (2007) 0.81

Antiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses. PLoS One (2015) 0.80

Mouse saliva inhibits transit of influenza virus to the lower respiratory tract by efficiently blocking influenza neuraminidase activity. J Virol (2017) 0.77

Salivary blockade protects the lower respiratory tract of mice from lethal influenza. J Virol (2017) 0.77

Pulmonary surfactant protein A protects lung epithelium from cytotoxicity of human β-defensin 3. J Biol Chem (2012) 0.76

Protective effect of surfactant protein d in pulmonary vaccinia virus infection: implication of A27 viral protein. Viruses (2013) 0.76

Identifying the Critical Domain of LL-37 Involved in Mediating Neutrophil Activation in the Presence of Influenza Virus: Functional and Structural Analysis. PLoS One (2015) 0.76

The Role of Antimicrobial Peptides in Influenza Virus Infection and Their Potential as Antiviral and Immunomodulatory Therapy. Pharmaceuticals (Basel) (2016) 0.75

A Role for Neutrophils in Viral Respiratory Disease. Front Immunol (2017) 0.75

Increased expression of deleted in malignant brain tumors (DMBT1) gene in precancerous gastric lesions: Findings from human and animal studies. Oncotarget (2017) 0.75

Structure, genetics and function of the pulmonary associated surfactant proteins A and D: The extra-pulmonary role of these C type lectins. Ann Anat (2017) 0.75

Articles by these authors

Lung environment determines unique phenotype of alveolar macrophages. Am J Physiol Lung Cell Mol Physiol (2009) 2.10

Human defensins and LL-37 in mucosal immunity. J Leukoc Biol (2009) 1.67

The Scavenger Receptor Cysteine-Rich (SRCR) domain: an ancient and highly conserved protein module of the innate immune system. Crit Rev Immunol (2004) 1.59

Collectin 11 (CL-11, CL-K1) is a MASP-1/3-associated plasma collectin with microbial-binding activity. J Immunol (2010) 1.47

Antiviral activity of the long chain pentraxin PTX3 against influenza viruses. J Immunol (2008) 1.39

A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D. J Immunol (2005) 1.36

Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammation. J Immunol (2006) 1.35

Tissue localization of human trefoil factors 1, 2, and 3. J Histochem Cytochem (2007) 1.31

Human neutrophil defensins increase neutrophil uptake of influenza A virus and bacteria and modify virus-induced respiratory burst responses. J Immunol (2007) 1.30

CRP-ductin, the mouse homologue of gp-340/deleted in malignant brain tumors 1 (DMBT1), binds gram-positive and gram-negative bacteria and interacts with lung surfactant protein D. Eur J Immunol (2003) 1.29

The lectin pathway of complement activation is a critical component of the innate immune response to pneumococcal infection. PLoS Pathog (2012) 1.28

Review: Gp-340/DMBT1 in mucosal innate immunity. Innate Immun (2010) 1.28

Transit-amplifying ductular (oval) cells and their hepatocytic progeny are characterized by a novel and distinctive expression of delta-like protein/preadipocyte factor 1/fetal antigen 1. Am J Pathol (2004) 1.25

Enhanced surfactant protein and defensin mRNA levels and reduced viral replication during parainfluenza virus type 3 pneumonia in neonatal lambs. Clin Diagn Lab Immunol (2004) 1.25

The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein D binding. Virology (2011) 1.25

Detection of novel biomarkers of liver cirrhosis by proteomic analysis. Hepatology (2009) 1.24

Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies. J Immunol (2010) 1.24

Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against influenza A viruses. Am J Physiol Lung Cell Mol Physiol (2003) 1.23

Interactions of alpha-, beta-, and theta-defensins with influenza A virus and surfactant protein D. J Immunol (2009) 1.22

Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology (2007) 1.21

Expression and localization of lung surfactant protein A in human tissues. Am J Respir Cell Mol Biol (2003) 1.21

The conserved scavenger receptor cysteine-rich superfamily in therapy and diagnosis. Pharmacol Rev (2011) 1.19

Neutrophil serine proteinases inactivate surfactant protein D by cleaving within a conserved subregion of the carbohydrate recognition domain. J Biol Chem (2004) 1.18

DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's disease. Gastroenterology (2007) 1.18

Ligand specificity of human surfactant protein D: expression of a mutant trimeric collectin that shows enhanced interactions with influenza A virus. J Biol Chem (2005) 1.17

Complementation of pulmonary abnormalities in SP-D(-/-) mice with an SP-D/conglutinin fusion protein. J Biol Chem (2002) 1.12

Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia. Clin Immunol (2003) 1.12

Contributions of the N- and C-terminal domains of surfactant protein d to the binding, aggregation, and phagocytic uptake of bacteria. Infect Immun (2002) 1.11

Reduced influenza viral neutralizing activity of natural human trimers of surfactant protein D. Respir Res (2007) 1.10

IL-4 and IL-13 form a negative feedback circuit with surfactant protein-D in the allergic airway response. J Immunol (2006) 1.10

Surfactant protein A and D differently regulate the immune response to nonmucoid Pseudomonas aeruginosa and its lipopolysaccharide. Am J Respir Cell Mol Biol (2003) 1.09

Species differences in the carbohydrate binding preferences of surfactant protein D. Am J Respir Cell Mol Biol (2006) 1.08

Respiratory innate immune proteins differentially modulate the neutrophil respiratory burst response to influenza A virus. Am J Physiol Lung Cell Mol Physiol (2005) 1.08

Heterogeneity of ductular reactions in adult rat and human liver revealed by novel expression of deleted in malignant brain tumor 1. Am J Pathol (2002) 1.07

Genetic and environmental influences of surfactant protein D serum levels. Am J Physiol Lung Cell Mol Physiol (2005) 1.06

New look at an old problem: bacterial superinfection after influenza. Am J Pathol (2009) 1.06

Cooperative anti-influenza activities of respiratory innate immune proteins and neuraminidase inhibitor. Am J Physiol Lung Cell Mol Physiol (2004) 1.06

Modification of surfactant protein D by reactive oxygen-nitrogen intermediates is accompanied by loss of aggregating activity, in vitro and in vivo. FASEB J (2009) 1.05

Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D. Respir Res (2008) 1.04

Interactions of influenza A virus with sialic acids present on porcine surfactant protein D. Am J Respir Cell Mol Biol (2003) 1.04

Salivary agglutinin and lung scavenger receptor cysteine-rich glycoprotein 340 have broad anti-influenza activities and interactions with surfactant protein D that vary according to donor source and sialylation. Biochem J (2006) 1.03

Porcine pulmonary collectins show distinct interactions with influenza A viruses: role of the N-linked oligosaccharides in the carbohydrate recognition domain. J Immunol (2003) 1.02

Role of surfactant protein A and D (SP-A and SP-D) in human antiviral host defense. Front Biosci (Schol Ed) (2010) 1.02

Characterization of FIBCD1 as an acetyl group-binding receptor that binds chitin. J Immunol (2009) 1.02

Surfactant protein D increases fusion of Mycobacterium tuberculosis-containing phagosomes with lysosomes in human macrophages. Infect Immun (2006) 1.01

Heteromeric complexes of native collectin kidney 1 and collectin liver 1 are found in the circulation with MASPs and activate the complement system. J Immunol (2013) 1.01

Surfactant protein D levels in umbilical cord blood and capillary blood of premature infants. The influence of perinatal factors. Pediatr Res (2006) 0.99

Innate immunity to influenza virus: implications for future therapy. Expert Rev Clin Immunol (2008) 0.99

Review: Structural determinants of pattern recognition by lung collectins. Innate Immun (2010) 0.99

Molecular and functional characterization of mouse S5D-SRCRB: a new group B member of the scavenger receptor cysteine-rich superfamily. J Immunol (2011) 0.98

The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins. J Gen Virol (2012) 0.98

Genetic influences on mannan-binding lectin (MBL) and mannan-binding lectin associated serine protease-2 (MASP-2) activity. Genet Epidemiol (2007) 0.98

Multimerization of surfactant protein D, but not its collagen domain, is required for antiviral and opsonic activities related to influenza virus. J Immunol (2008) 0.97

Ficolins and FIBCD1: soluble and membrane bound pattern recognition molecules with acetyl group selectivity. Mol Immunol (2010) 0.96

Distinctive anti-influenza properties of recombinant collectin 43. Biochem J (2002) 0.95

Frequent downregulation of DMBT1 and galectin-3 in epithelial skin cancer. Int J Cancer (2003) 0.95

The SRCR/SID region of DMBT1 defines a complex multi-allele system representing the major basis for its variability in cancer. Genes Chromosomes Cancer (2002) 0.94

Patterns of neutrophil serine protease-dependent cleavage of surfactant protein D in inflammatory lung disease. J Leukoc Biol (2008) 0.94

Critical role for cross-linking of trimeric lectin domains of surfactant protein D in antiviral activity against influenza A virus. Biochem J (2008) 0.94

Surfactant protein D expression in normal and pneumonic ovine lung. Vet Immunol Immunopathol (2004) 0.93

Lack of the pattern recognition molecule mannose-binding lectin increases susceptibility to influenza A virus infection. BMC Immunol (2010) 0.93

Surfactant protein D binds to human immunodeficiency virus (HIV) envelope protein gp120 and inhibits HIV replication. J Gen Virol (2005) 0.93

Impact of neutrophils on antiviral activity of human bronchoalveolar lavage fluid. Am J Physiol Lung Cell Mol Physiol (2007) 0.93

GM-CSF modulates pulmonary resistance to influenza A infection. Antiviral Res (2011) 0.92

The effects of GH and hormone replacement therapy on serum concentrations of mannan-binding lectin, surfactant protein D and vitamin D binding protein in Turner syndrome. Eur J Endocrinol (2004) 0.92

Surfactant proteins A and D enhance the phagocytosis of Chlamydia into THP-1 cells. Am J Physiol Lung Cell Mol Physiol (2004) 0.92

Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis. J Cyst Fibros (2010) 0.92

DMBT1 functions as pattern-recognition molecule for poly-sulfated and poly-phosphorylated ligands. Eur J Immunol (2009) 0.91

Long-term stability and circadian variation in circulating levels of surfactant protein D. Immunobiology (2009) 0.91

Antigenic relationships between six genotypes of the small hydrophobic protein gene of mumps virus. J Gen Virol (2002) 0.91

Effective targeting of pathogens to neutrophils via chimeric surfactant protein D/anti-CD89 protein. J Immunol (2004) 0.91

Carcinogen inducibility in vivo and down-regulation of DMBT1 during breast carcinogenesis. Genes Chromosomes Cancer (2004) 0.91

Sequential changes of the DMBT1 expression and location in normal lung tissue and lung carcinomas. Genes Chromosomes Cancer (2002) 0.91

Surfactant protein D-mediated aggregation of Pneumocystis carinii impairs phagocytosis by alveolar macrophages. Infect Immun (2003) 0.91

Surfactant protein D augments bacterial association but attenuates major histocompatibility complex class II presentation of bacterial antigens. Am J Respir Cell Mol Biol (2006) 0.91

CL-46, a novel collectin highly expressed in bovine thymus and liver. J Immunol (2002) 0.90

Recombinant chimeric lectins consisting of mannose-binding lectin and L-ficolin are potent inhibitors of influenza A virus compared with mannose-binding lectin. Biochem Pharmacol (2010) 0.90

Induction of DMBT1 expression by reduced ERK activity during a gastric mucosa differentiation-like process and its association with human gastric cancer. Carcinogenesis (2005) 0.90

Heritability estimates for the constitutional levels of the collectins mannan-binding lectin and lung surfactant protein D. A study of unselected like-sexed mono- and dizygotic twins at the age of 6-9 years. Immunology (2002) 0.87